© 2015 Fox Rothschild Inter Partes Review Lessons Learned Scott R. Bialecki Fox Rothschild LLP June 24, 2015.

Slides:



Advertisements
Similar presentations
By David W. Hill AIPLA Immediate Past President Partner Finnegan, Henderson, Farabow, Garrett & Dunner, LLP Overview of the America Invents Act.
Advertisements

Webinar: Request for Comments on AIA Trial Proceedings Before the PTAB July 29, Scott Boalick, Vice Chief Judge (Acting) Patent Trial and Appeal.
© Kolisch Hartwell 2013 All Rights Reserved, Page 1 America Invents Act (AIA) Implementation in 2012 Peter D. Sabido Intellectual Property Attorney Kolisch.
Update on Alabama Appellate Practice & Procedure: Avoiding Malpractice When Handling Appeals DEBORAH ALLEY SMITH.
What Do In-House Counsel Need to Know? AIA Proceedings Molly Kocialski, Senior Patent Counsel, Oracle Dion Messer, General Counsel - IP, Limelight Networks.
PROSECUTION APPEALS Presented at: Webb & Co. Rehovot, Israel Date: February 14, 2013 Presented by: Roy D. Gross Associate St. Onge Steward Johnston & Reens.
Speeding It Up at the USPTO July 2013 July 23, 2013.
Post-Issuance Proceedings Under the AIA Thomas F. Cotter Briggs and Morgan Professor of Law University of Minnesota Law School.
BIPC.COM STRATEGIC CONSIDERATIONS OF POST ISSUANCE PATENTABILITY REVIEW: THE NEW, OLD, AND NO LONGER Presented By: Todd R. Walters, Esq. B UCHANAN, I NGERSOLL.
Administrative Trials
Filing Compliant Reexam Requests Andy Kashnikow SPE, Central Reexamination Unit Andy Kashnikow SPE, Central Reexamination Unit June, 2010.
1 1 AIPLA Firm Logo 1 AIPLA Firm Logo American Intellectual Property Law Association CURRENT TRENDS/EFFECTS OF AIA on US Patent Practice at the US Patent.
Greg H. Gardella Ex Parte and Inter Partes Reexamination Tactics AIPLA 2010 Winter Institute.
1 1 AIPLA Firm Logo American Intellectual Property Law Association Counseling Clients re New USPTO Post Grant Proceedings and Interplay with Litigation.
AIA Strategies.
A Comparative Analysis of Patent Post-Grant Review Procedures in the U
Administrative Estoppel May 28, Estoppel/Preclusion Generally Elements of Collateral Estoppel / Res Judicata: –A right, question, or fact –in issue.
PRESENTATION TITLE 1 America Invents Act: Creating “Rocket Docket” Patent Trials in the Patent Office.
Remy Yucel Director, CRU (571) Central Reexamination Unit and the AIA.
Post-Grant Proceedings Under The America Invents Act Los Angeles Intellectual Property Law Association “Washington in the West” Conference January 29,
Impact of US AIA: What Really Changed? 1 © AIPLA 2015.
1 Patent Law in the Age of IoT The Landscape Has Shifted. Are You Prepared? 1 Jeffrey A. Miller, Esq.
1 1 AIPLA Firm Logo American Intellectual Property Law Association Update on Inter Partes Disputes and the PTAB _____ John B. Pegram Fish & Richardson.
Christopher J. Fildes Fildes & Outland, P.C. Derivation Proceedings and Prior User Rights.
1 1 AIPLA Firm Logo American Intellectual Property Law Association EMERGING TRENDS IN INTER PARTES REVIEW PRACTICE TOM ENGELLENNER Pepper Hamilton, LLP.
Post-Grant & Inter Partes Review Procedures Presented to AIPPI, Italy February 10, 2012 By Joerg-Uwe Szipl Griffin & Szipl, P.C.
1 Rules of Practice Before the BPAI in Ex Parte Appeals 73 Fed. Reg (June 10, 2008) Effective December 10, Fed. Reg (June 10, 2008)
1 1 AIPLA Firm Logo American Intellectual Property Law Association Update on AIA Implementation Especially post grant processes Alan J. Kasper AIPLA/JPO.
1 1 AIPLA Firm Logo American Intellectual Property Law Association The Presumption of Patent Validity in the U.S. Tom Engellenner AIPLA Presentation to.
1 1 AIPLA Firm Logo American Intellectual Property Law Association Interplay between Litigation and the AIA __________ An Overview John B. Pegram Fish.
Challenges Associated With, And Strategies For, U.S. Patent Litigation Russell E. Levine, P.C. Kirkland & Ellis LLP LES Asia.
1 1 AIPLA Firm Logo American Intellectual Property Law Association PTAB Update: IPR & CBM Sponsored by the Japan Patent Office Ron Harris, The Harris Firm.
Patent Prosecution May PCT- RCE Zombie 371 National Stage PCT Applications –Not Allowed to file an RCE until signed inventor oath/declaration is.
New Ex Parte Appeal Rules Patent and Trademark Practice Group Meeting January 26, 2012.
© COPYRIGHT DICKSTEIN SHAPIRO LLP. ALL RIGHTS RESERVED. Post Grant Proceedings Before the USPTO and Litigation Strategies Under the AIA Panelists:David.
America Invents Act  Date of enactment: 9/16/11  First-to-file provisions effective 18 months after enactment – March 16, 2013  Applications filed on.
The New Tool for Patent Defendants - Inter Partes Review Daniel W. McDonald George C. Lewis, P.E. Merchant & Gould, P.C. April 16, 2014 © 2014 Merchant.
TOM ENGELLENNER Pepper Hamilton, LLP IP in Japan Committee Meeting AIPLA Annual Meeting, Washington D.C. October, 2015 USPTO Rule Changes and IPR Procedures.
Peter C. Schechter Vice-Chair, AIPPI-US Div. of AIPLA Partner, Osha Liang LLP Post-Issuance Review Proceedings: Update & Trends in IPR & PGR 1 © AIPLA.
1 1 American Intellectual Property Law Association Inter Partes Review: Recent Cases STEVEN F. MEYER AIPLA IP in Japan Committee Annual Pre-Meeting October.
Derivation Proceedings Gene Quinn Patent Attorney IPWatchdog.com March 27 th, 2012.
Patent Reexamination: Best Practices for Pursuing and Defending Parallel Reexamination and Litigation.
PTAB Litigation 2016 Part 6 – Patent Owner Response 1.
PTAB Litigation 2016 Part 2 – The Petition 1. The Petition 2.
PTAB Litigation 2016 Part 7 – Petitioner Reply and Motion to Exclude 1.
Using the Patent Review Processing System (PRPS) for Post Grant Pilot Applications How to identify relevant information in AIA proceedings at the Patent.
Presentation at Biotechnology/ Chemical/Pharmaceutical Customer Partnership Program Partnership Program March 15, 2005 POST-GRANT REVIEW: A COMPARISON.
PTAB Litigation 2016 Part 9 – Final Written Decision and Appeal 1.
PTAB Litigation 2016 Part 5 – Motions Practice, Discovery, and Trial Management Issues 1.
Recent Developments in Obtaining and Enforcing Intellectual Property Rights in Nanocomposites Michael P. Dilworth February 28, 2012.
PTAB Litigation 2016 Part 3 – The Patent Owner Preliminary Response 1.
ptab game theory: patent owner versus petitioner
Omer/LES International/
Inter Partes Review and District Court
PTAB Litigation 2016 Part 1 – PTAB Basics and Procedure
PTAB Litigation 2016 Part 12 – PTAB Popularity and Reasons
POST Grant RevieW UPDATES
CBM/PGR Differences Differences in time periods of availability, parties who have standing, grounds of challenge available, standards of review, and.
USPTO Appeal Process: Appeal Strategies and New Rules
Orrick, Herrington & Sutcliffe LLP Mark Wine June 6, 2014
Mark P. Wine Orrick, Herrington & Sutcliffe LLP June 6, 2014
Inter Partes Review Best Practices 2018
PTAB Bootcamp: Nuts and Bolts of IPRs, PGRs, and CBMs
Karl Renner Dorothy Whelan Chris Marchese
PTAB Litigation 2016 Part 8 – Oral Hearing
SAS Institute v. Iancu SAS appeals arguing § 318 requires deciding patentability of all claims challenged ComlimentSoft sues SAS for patent infringement.
PTAB Litigation 2016 Part 4 – The Institution Decision
PTAB Bar Association Conference—March 2, 2017
James Toupin POST-GRANT REVIEW: A COMPARISON OF USPTO
The Other 66 Percent: Appeals Before the PTAB
Presentation transcript:

© 2015 Fox Rothschild Inter Partes Review Lessons Learned Scott R. Bialecki Fox Rothschild LLP June 24, 2015

The 10,000 Foot View Inter Partes Review (“IPR”) is a relatively new procedure under the AIA for challenging patent validity at the USPTO. Considered to be faster and have a better success rate than previous options. Only based on prior art patents or printed publications. 2

Inter Partes Review District Court Decided ByPTAB panelJudge/Jury Timing1.5 years1.5 – 4 years Burden of Proof Preponderance of the evidence Clear and convincing evidence Claim Construction Standard Broadest reasonable interpretation Construe to maintain validity IPR vs. District Court 3

Inter Partes ReviewEx Parte Reexam Decided ByPTAB PanelPatent Examiner Timing1.5 years 3 mos. to institute/ No final deadline Basis for Instituting Reasonable likelihood of success for at least 1 claim Substantial new question of patentability Estoppel Raised or could reasonably have been raised None Participation Throughout process/ right to appeal final decision Limited to initial filing/ no right to appeal final decision Basis Patents & printed publications Same IPR vs. Ex Parte Reexam 4

Final Written Decision Oral Hearing PO Reply on Motion to Amend Petitioner Reply & Opposition to Amendment PO Response & Motion to Amend Claims Decision on Petition PO Preliminary Response Petition Filed 3 months 7 months No more than 12 months* *Possible 6-month extension No more than 6 months 5

Timing WHEN: 6 IF IN LITIGATION, YOU MUST FILE IPR PETITION WITHIN 1 YEAR OF COMPLAINT. Follow the Five Month Rule. PTAB makes institution decisions within 6 months. Five Month Rule leaves a 1 month turnaround.

Fees Can Add Up Quickly Petition 7 $9,000 + $200 for each claim over 20. (Non-refundable if petition denied) $14,000 + $400 for each claim over 15. (Refundable if petition is denied) Min USPTO Filing Fee = $23,000 Institution + Attorneys’ Fees +

617 Petitions Filed (as of 1/15/15) 9,048 Claims Challenged 68% of Claims Challenged Were Instituted 32% of Claims Challenged Were Not Instituted Source: USPTO IPR Statistics (as of 1/15/15) 51% of Claims Instituted Did Not Survive IPR 8

What We’ve Learned: Estoppel Q: What counts as “could have raised”? A: This includes “prior art which a skilled searcher conducting a diligent search reasonably could have been expected to discover.” IPR , Dkt. 10, at 5. 9 Concept: Estoppel applies only for grounds that petitioner raised or reasonably could have raised.

Practice Pointer: Estoppel Star Envirotech, Inc. v. Redline Detection, LLC, Case No. SACV JGB (DFMx) (C.D.Cal. 1/29/15) –Instruction manual case –LeakMaster A240 smoke machine “locating a heating element within a closed smoke producing chamber” TIP: Make sure to analyze manuals relating to devices to avoid estoppel issue 10

What We’ve Learned: Estoppel Cont’d Q: What counts as a “final written decision”? A: This does not include denial of a petition for institution. It only applies to the PTAB’s decisions after institution. 35 U.S.C. §§ 315(e)(2) and 318(a) 11 Concept: Estoppel applies only if there was a final written decision.

What We’ve Learned: Incorporation By Reference “The footnotes cite a total of seventeen pages, including eleven pages of claim charts, of Dr. Roy’s Declaration— substantially more pages than section VII-A in the Petition.... The practice, here, of using footnotes to cite large portions of another document, without sufficient explanation of those portions, amounts to [an improper] incorporation by reference.” IPR , Dkt. 12, at Concept: The PTAB follows a strict 60-page, double-space, 14 pt. font rule. Petitioners who try to skirt this rule by incorporating exhibits by reference risk getting their petitions bounced.

What We’ve Learned: Staying District Court Litigation Q: What are ways to increase chances of a stay? A: You have a better chance of a stay if: You ask for it after the IPR is instituted; All patents, claims, and parties are involved in the IPR; and/or You can show minimal prejudice to opposing side. 13 Staying District Court litigation is not guaranteed, so proceed with caution. Concept: Staying District Court litigation is not guaranteed, so proceed with caution.

4 Revised IPR Rules Effective May 19, 2015 Page Limits in Patent Owner’s Motion to Amend –25 pages (up from 15) / Opposition has same 25 page limit –Proposed amended claims can be presented in appendix Petitioner Reply Brief Page Limit –25 Pages (up from 15) Easier now to respond to Patent Owner Response brief of 60 pages Required Font –Font games are over: 14-point, Times New Roman Multiple Back-Up Counsel Allowed 14

The Fight Against Hedge Funds Abuse of IPR Process –Motion for Sanctions briefing moving forward Bass and related companies “abusing IPR process for private financial gain”; 37 C.F.R.§§ 42.12(a)(6), b(8) Celgene Corp., IPR (Jun. 9, 2015) Fail to Disclose All Investors: Real Parties-In-Interest –Motion for Additional RPI Discovery NPS Pharmaceuticals Inc., IPR (Jun. 3, 2015) –Preliminary Response Arguing Failure to Disclose RPIs Acorda Therapeutics, IPR (May 26, 2015) 15

Questions? Fox Rothschild LLP Scott R. Bialecki (303)